More on Semaglutide in Early Type 1 Diabetes

N Engl J Med. 2024 Jan 18;390(3):290. doi: 10.1056/NEJMc2311608.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 1* / drug therapy
  • Glucagon-Like Peptides / therapeutic use
  • Humans
  • Hypoglycemic Agents / therapeutic use

Substances

  • semaglutide
  • Glucagon-Like Peptides
  • Hypoglycemic Agents